With Novartis deal dead, Proteon turns to Plan B: IPO

Proteon Therapeutics Inc. is planning an initial public offering according to a Tuesday filing with the Securities and Exchange Commission...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.